Principal Investigator
Hongming Pan, MD,PhD
Sir Run Run Shaw Hospital
Total Trials
1
As PI
1
Completed
0
h-index
N/A
Publications
0
Years Active
0
Research Impact
h-index
N/A
Research impact score
Publications
0
Total publications
Trial Results
0
Published trial results
Citations
0
Total citations
Drug Portfolio
Analytics
Trial Phases
Phase 11
Trial Status
Terminated1
Role Distribution
Principal Investigator1
PI Rate100%
Activity Timeline
Clinical Trials (1)
A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors
Malignant Neoplasm of Digestive System
PrincipalinvestigatorStart date: 2022-05-13
Research Network
Collaboration Network
6 collaborators·9 connections
Network Legend
KOL
Current InvestigatorCO
High-influence CollaboratorCO
CollaboratorClick: view details
Double-click: go to profile
Drag: move node
Research Areas & Affiliations
Therapeutic Areas
Affiliations
Sir Run Run Shaw Hospital
Similar Key Opinion Leaders
Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.
2 similar investigators found
Yanshan Huang, PhD
Zhejiang Doer Biologics Co., Ltd.
3 trials
Shared therapeutic areas:
Malignant Neoplasm of Digestive System
Worked with same sponsors:
Zhejiang Doer Biologics Co., Ltd.
Collaborated on 1 trial
Similarity Score14%
Junfang Xu, MD
Huadong Medicine Co., Ltd.
3 trials
Shared therapeutic areas:
Malignant Neoplasm of Digestive System
Worked with same sponsors:
Zhejiang Doer Biologics Co., Ltd.
Collaborated on 1 trial
Similarity Score14%
Publications (0)
No publications found for this investigator.
Clinical Trials (1)
Showing 1 of 1 trials
A Trial to Evaluate the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of DR30303 in Patients With Advanced Solid Tumors
Malignant Neoplasm of Digestive System
All 1 trials loaded